MFS
PETX

MSI Financial Services’s Aratana Therapeutics, Inc. PETX Stock Holding History

MSI Financial Services’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3K Hold
360
– – ﹤0.01% 3421
2016
Q3 		$3K Buy
360
+60
+20% +$498 ﹤0.01% 3407
2016
Q2 		$2K Buy
+300
New +$1.93K ﹤0.01% 3605

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MSI Financial Services's PETX Position: Q4 2016 in Review

MSI Financial Services held its Aratana Therapeutics, Inc. (PETX) position steady in Q4 2016 at 360 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #3421.

MSI Financial Services first reported a position in PETX in Q2 2016 and has held it in 3 quarters since. 107 funds tracked by Wall St. Rank hold PETX as of Q4 2016.

  • MSI Financial Services held 360 shares of Aratana Therapeutics, Inc. worth $3K as of Q4 2016.
  • MSI Financial Services left its Aratana Therapeutics, Inc. share count unchanged in Q4 2016.
  • Aratana Therapeutics, Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3421 holding.
  • MSI Financial Services first reported a position in Aratana Therapeutics, Inc. in Q2 2016 and has held it in 3 quarters since.
  • 107 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.